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Edited by Jesus AvilaAbstract Presynaptic nerve terminals contain scaﬀolding pro-
teins that orchestrate neurotransmitter release at active zones.
Here we describe mover, a yet unknown non-transmembrane pro-
tein that is targeted to presynaptic terminals when overexpressed
in cultured neurons. Confocal immunomicroscopy revealed that
mover colocalizes with presynaptic markers in the calyx of Held.
In the hippocampus, mover localizes to mossy ﬁbre terminals, but
is absent from inhibitory nerve terminals. By contrast, mover
localizes to inhibitory terminals throughout the cerebellar cortex.
Our results suggest that mover may act in concert with generally
expressed scaﬀolding proteins in distinct sets of presynaptic ter-
minals.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Calyx of Held1. Introduction
Synapses of the central nervous system are specialized sites
of cell–cell contact. The presynaptic site is designed to allow
for highly regulated, exocytotic neurotransmitter release from
synaptic vesicles (SVs) [1]. The majority of proteins involved in
neurotransmitter release are evolutionarily conserved among
vertebrates and invertebrates and include two types of protein
complexes, which are crucially involved in neurotransmitter
release: ﬁrst, SNARE-complexes, built from the SV-transmem-
brane protein VAMP and the plasmamembrane proteins syn-
taxin-1 and SNAP25 which mediate exocytotic fusion of SVs
with the plasmamembrane [2]. Second, the cytomatrix of active
zones (CAZ) which is thought to represent a supramolecular
complex serving several functions, including formation of a
scaﬀold for the recruitment of additional proteins by organiz-
ing presynaptic protein–protein interactions, regulation of
SNARE-complexes, and spatial restriction of SV fusion to
active zones [3–5].
The expression of two related multidomain CAZ-proteins,
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doi:10.1016/j.febslet.2007.08.070brates and therefore may add vertebrate-speciﬁc features to
presynaptic nerve terminals [5]. To identify novel vertebrate
speciﬁc presynaptic proteins, we performed a yeast-2-hybrid
screen using one of the cognate vertebrate speciﬁc CAZ-com-
ponents, namely bassoon, as bait.
Here, we describe the tissue distribution and subcellular
localization of a putative bassoon binding partner, which we
call mover alluding to its association with mossy ﬁbre terminals
and its exclusive expression in vertebrates. We show that
mover is a presynaptic molecule with diﬀerential distribution
at distinct sets of excitatory and inhibitory synapses.2. Materials and methods
2.1. Antibodies
Primary antibodies: anti-myc (9E10; Santa Cruz), anti-MAP-2, anti-
synapsin, anti-synaptophysin (Sigma), anti-bassoon (Stressgen), anti-
synaptotagmin 1, anti-VGAT (Synaptic Systems). Rabbit polyclonal
antibodies were raised against mover fused to glutathione-S-transfer-
ase (GST). Mover-speciﬁc antibodies were puriﬁed using two aﬃnity
columns (Sterogene).
2.2. Yeast-2-hybrid screen
Screening was performed using the L40 yeast strain harbouring
HIS3 and b-gal as reporter gene. Nucleotide sequences encoding amino
acids 3263–3938 of rat bassoon were subcloned into the lexA fusion
vector pHyblexZeo and used to screen an adult mouse brain cDNA
library constructed in pPC86 vector containing the GAL4 activation
domain vector (Invitrogen). Approximately 2 · 107 clones of a mouse
cDNA library were screened. Positive clones of the initial screen were
isolated, sequenced and retransformed to validate their ability to bind
to the respective bassoon fragment.
2.3. Constructs
The rat mover cDNA was cloned from rat brain total RNA by
RT-PCR with oligonucleotides based on the 5 0- and 3 0-terminal mouse
sequences, and subcloned into CMV-promotor based mammalian
expression vectors (Clontech). The myc-sequence was fused to the
C-terminus of full-length rat mover. Further constructs were synapto-
physin-GFP and PSD-95-GFP [6,7].
2.4. Cell culture
Primary cultures of rat hippocampal neurons were prepared, main-
tained and transfected using the calcium phosphate method on DIV 3
or 4 as described [8].
2.5. Immunocytochemistry and ﬂuorescence imaging
Cultured neurons were ﬁxed in 4% paraformaldehyde, processed and
viewed as described [8]. Adult rats were perfused with phosphate
buﬀered saline (PBS) containing 4% paraformaldehyde, 2% polyvinyl-
pyrrolidone, and 0.01% glutaraldehyde. The ﬁxed tissue was kept inblished by Elsevier B.V. All rights reserved.
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increasing sucrose concentrations, frozen in embedding medium (Tis-
sue Tek) on dry ice and sectioned at 20 lm on a cryostat. Confocal
images were acquired using a Leica TSC SP confocal microscope.2.6. Subcellular fractionation of adult rat brain
Fractionation was performed as described [9,10]. The individual
fractions were designated as follows: Hom, homogenate; P1, nuclear
pellet; S1, supernatant after synaptosome sedimentation; P2, crude
synaptosomal pellet; P3, light membrane pellet; S3, cytosolic fraction;
LP2, crude synaptic vesicle fraction; LS2, cytosolic synaptosomal frac-
tion; SPM, synaptic plasma membranes.2.7. Synaptotagmin uptake assay
This assay identiﬁes functional neurotransmitter release sites by
stimulation-dependent uptake of an antibody that binds to the lume-
nal domain of the synaptic vesicle transmembrane protein synapto-
tagmin-1 [11]. Hippocampal neurons transfected with a myc-tagged
mover construct were incubated for 90 s with anti-synaptotagmin-1
antibody in depolarisation buﬀer (44 mM NaCl, 90 mM KCl,
2 mM CaCl2, 1 mM MgCl2, 20 mM HEPES pH 7.4, 30 mM glu-
cose) followed by a 10 min incubation with anti-synaptotagmin-1
antibody in culture medium at 37 C. After washing and ﬁxation,
the internalized antibodies were detected using anti-mouse secondary
antibodies.Fig. 1. Sequence alignment of rat (r-mover) with mouse (m-mover), human
Computational analysis predicts no known functional domains or conse
(Phosphothreonine).2.8. Northern blotting
A premade multiple tissue Northern blot (BD) was hybridized with
32P-labelled mover cDNA for 1 h at 68 C, washed three times with
2·SSC, 0.05% SDS, followed by two washes of 1·SSC, 0.1% SDS at
50 C. To check for equal loading, the blot was stripped and re-probed
with radioactively labelled human b-actin cDNA.3. Results
The most abundant prey in the yeast-2-hybrid screen was a
cDNA encoding a 266 amino acid protein, which we propose
to name mover. Murine mover cDNA is found in the NCBI
database as RIKEN cDNA 1200015A19 gene encoding a hypo-
thetical protein (GenBank accession number NP_080664).
Mover homologues exist in vertebrates, but not in invertebrates.
Because rat mover sequences were not deposited, we used
RT-PCR to clone a rat mover cDNA, which encodes a protein
with 99% amino acid sequence identity to murine mover
(Fig. 1). Sequence comparison of several homologues revealed
a divergent N-terminal region followed by evolutionary
conserved regions. Mover has no predicted transmembrane
domains or putative membrane anchor sites (Fig. 1).(h-mover), zebraﬁsh (z-mover) and Xenopus laevis (x-mover) mover.
rved motifs. Mover has a predicted phosphorylation site at aa13
Fig. 2. Mover expression in adult rat tissue. (A) Northern Blot analysis. An actin-cDNA probe was used as a loading control. Marker lane: 2.4 kb.
(B) Mover protein expression (10 lg protein per lane). In skeletal muscle, a weak 40 kD band is detectable (asterisk).
Fig. 3. Subcellular fractions of rat brain homogenate analyzed by
Western Blot using aﬃnity puriﬁed mover antibodies. Homogenate
(Hom); nuclei (P1); supernatant after synaptosome sedimentation (S1);
crude synaptosomal pellet (P2); light membrane pellet (P3); cytosolic
fraction (S3); cytosolic synaptosomal fraction (LS2); crude synaptic
vesicle fraction (LP2); synaptic plasma membranes (SPM).
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mRNA in brain, and also in heart, liver, kidney and testis
(Fig. 2A). We generated an antiserum against mover, which
detected a single band in Western blots of tissue homogenates
and lysates prepared from cultured neurons (Fig. 2B and data
not shown). Protein levels of mover are highest in the brain.
Mover is also expressed in testis, while there is relatively weak
expression in heart, spleen and liver (Fig. 2B). Upon subcellu-
lar fractionation of adult rat brain homogenate, mover be-
haved similar to the SV-marker protein synaptophysin being
abundant in the LP2 fraction, which is enriched for synaptic
vesicles. Mover was not enriched in the SPM-fraction contain-
ing synaptic plasma membranes as well as pre- and postsynap-
tic scaﬀolding proteins such as PSD-95 (Fig. 3). Moreover,
mover levels were lower in cytosolic protein fractions than in
all other fractions. These results suggest that mover may be
a protein of presynaptic nerve terminals.
To further test this hypothesis, we performed immunoﬂuo-
rescence localization studies. In cultured rat hippocampal neu-
rons, mover was diﬀusely distributed in the somatodendritic
region but enriched in puncta, which co-localized with synap-
tophysin (Fig. 4A). Synaptotagmin antibody-uptake assays
identiﬁed these puncta as functional neurotransmitter release
sites (Fig. 4B). Moreover, like the synaptic vesicle protein syn-
aptophysin but unlike the CAZ protein bassoon, mover could
be extracted by Triton X-100 treatment of live cultured neu-
rons Fig. S3 [8].
We next generated recombinant versions of mover fused to
N- or C-terminal tags, including myc, GFP and mCherry.
When co-expressed in HEK293-cells recombinant mover and
bassoon constructs co-aggregated. In co-immunoprecipita-
tion attempts recombinant mover turned out to be largely
insoluble, however (data not shown). This observation pre-
cluded additional co-precipitation attempts.
Fig. 4. Synaptic localization of mover in cultured hippocampal neurons. (A) Neurons were ﬁxed and double-immunolabelled for mover and
synaptophysin (SyPh). (B) Neurons were ﬁxed after stimulation in the presence of anti-synaptotagmin antibodies (to load active synapses with the
antibody) and immunolabelled for mover. Bar, 30 lm.
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neuronal environment, we expressed myc-tagged mover in cul-
tured neurons and analyzed its traﬃcking in individual cells. In
neurons cultured for more than 9 days, myc-tagged mover was
concentrated in synapsin containing puncta at various dis-
tances from the soma (Fig. 5A). Upon co-expression, mover-
myc and synaptophysin-GFP displayed identical distribution
patterns outside the somatodendritic region and completeoverlapping of mover-myc, synaptophysin-GFP and endoge-
nous synapsin immunoreactivities (Fig. 5B). By contrast, when
co-expressed with the postsynaptic marker construct PSD-95-
GFP, divergent distributions were observed. Interestingly, no
enrichment of mover-myc and PSD-95 puncta was observed,
even in cells expressing high levels of mover-myc, where a uni-
form distribution of mover immunoreactivity (IR) in the soma-
dendritic compartment was observed (Fig. 5C). From these
Fig. 5. Presynaptic targeting of mover-myc in cultured hippocampal
neurons. Neurons were ﬁxed and immunolabelled with anti-myc
antibody. (A) Punctate mover-myc immunoreactivity colocalizes with
endogenous synapsin. (B) Both mover-myc and synaptophysin-GFP
co-localize with endogenous synapsin immunoreactivity in a double-
transfected neuron. (C) Mover-myc immunoreactivity and PSD-95-
GFP do not co-localize in a double-transfected neuron (arrows). Bars,
30 lm.
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geted to presynaptic sites.
To investigate whether mover is localized to synapses in the
brain, we immunostained brain regions harboring well-charac-
terized types of presynaptic nerve terminals, including the ca-
lyx of Held in the auditory brain stem, mossy ﬁbre boutons
in the hippocampus and mossy ﬁbre terminals in the cerebel-
lum. In the calyx of Held, a giant synaptic terminal that forms
around the soma of principal cells in the medial nucleus of the
trapezoid body (MNTB), mover immunoreactivity (IR) is en-
riched in the presynaptic compartment and showed a punctate
staining that co-localized with synaptophysin IR (Fig. 6A) but
was absent from the soma of the postsynaptic cell.
In the hippocampal CA3 region, mover IR was enriched in
the stratum lucidum, the region harboring mossy ﬁbre termi-
nals and not in the stratum pyramidale, harboring the cell
bodies of pyramidal neurons (Fig. 6B–D). Higher magniﬁca-
tion revealed punctate mover IR along MAP-2 stained
dendrites (Fig. 6B), which co-localized with that of synapto-
physin (Fig. 6C) and VGLUT1 (data not shown). Mover IR
did not colocalize with VGAT suggesting its absence from
inhibitory synapses in the CA3 region (Fig. 6D). By contrast,
in the cerebellum VGAT-positive puncta co-localized with
mover IR (Fig. 6E). VGAT positive presynaptic terminals of
basket and stellate cells and of recurrent Purkinje cells axons
providing inhibitory input to the molecular layer and Purkinje
cell layer co-localized extensively with mover IR. Likewise, in
the granular layer, VGAT co-localized with mover at synaptic
glomeruli (Fig. 6E), harbouring inhibitory presynaptic termi-
nals of Golgi cells [12], but not with VGLUT1 (data not
shown). Thus, mover appears to be absent from inhibitory
nerve terminals in the hippocampal CA3-region, whereas it is
present at inhibitory terminals in all layers of the cerebellar
cortex.4. Discussion
We identiﬁed a hitherto unknown protein, which is speciﬁ-
cally expressed in vertebrates and found in many tissues, pre-
dominantly brain. Subcellular fractionation of brain tissue
suggests that the novel protein, which we call mover, is en-
riched in the synaptic vesicle fraction. This notion is further
corroborated by targeting and colocalisation studies. Mover
IR gives a synaptic staining pattern at several well-character-
ized synapses of the brain. The observation that the recombi-
nant protein has presynaptic, but not postsynaptic targeting
capacity strongly suggests that the staining observed in the
brain reﬂects presynaptic localization. This is supported fur-
ther by the colocalization of mover with presynaptic markers
in the calyx of Held and the absence of mover IR in the soma
of cognate postsynaptic cells.
Although no transmembrane region or putative sites for
membrane anchoring are predicted from the primary structure,
mover was enriched in the synaptosomal fraction upon bio-
chemical fractionation and localized to synapses both in neu-
ronal cultures and the brain. These data are consistent with
the assumption that mover binds to synaptic organelles such
as SVs.
Furthermore, mover bound to a C-terminal portion of bas-
soon in yeast, co-localized with bassoon in neurons and the
Fig. 6. Diﬀerential localization of mover to subsets of synapses in the brain. A–E show an overview for the double-staining for mover and the
respective markers in diﬀerent areas of the brain. (A) Calyx of Held. (B–D) CA3 region of rat hippocampus. (E) Cerebellar cortex. Double-staining
for mover and MAP2 (B), mover and synaptophysin (A, C) or mover and VGAT (D, E). SR, stratum radiatum, SL, stratum lucidum, SP, stratum
pyramidale. GL, granular layer, PJ, Purkinje cell layer, ML, molecular layer. A 0–E 0 show corresponding merged images and the respective single
channels at higher magniﬁcation (2.5·). The images shown in lane B 0 and C 0 are derived from the corresponding ﬁeld. Bars, 30 lm.
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in HEK293-cells. These data are consistent with the assump-
tion that mover can bind to bassoon in vivo. As recombinant
mover is insoluble, it was not possible to test this assumption
by co-immunoprecipitation, however. The sensitivity of mover
IR to Triton X-100 extraction of live cultures indicates that
mover is not an integral component of the CAZ-network,
but may rather be a vertebrate-speciﬁc CAZ-associated pro-
tein. This would be consistent with the fact that mover is pres-
ent but not concentrated in the synaptic plasma membrane
fraction, which is enriched for CAZ-proteins [9].
Surprisingly, mover is diﬀerentially localized to subsets of
synapses. Whereas in CA3 it is found at excitatory synapses,
in cerebellar cortex mover is found at inhibitory terminals.
Interestingly, several pan-neuronally expressed presynapticproteins seem to have distinct roles at excitatory and inhibitory
synapses, respectively. For example, knock-outs of the genes
for synapsin or RIM aﬀect excitatory and inhibitory transmis-
sion in diﬀerent ways, although these proteins are present at
both types of synapses [13,14]. Similarly, bassoon is expressed
at excitatory and inhibitory synapses throughout the brain, but
deletions in the bassoon gene cause silencing of only a fraction
of synapses, as well as an epileptic phenotype, suggesting an
imbalance between excitation and inhibition in these animals
[15]. Mover could account for such eﬀects by functioning as
an eﬀector for CAZ-proteins in speciﬁc sets of synapses.Acknowledgements: We are grateful to Karin Gorgas and Gabi Kra¨-
mer. This work was supported by the DFG Grants Ki 339/10-1 (to.
J.K.) and DR373/3-2 (to T.D.).
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found, in the online version, at doi:10.1016/j.febslet.2007.08.
070.
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